
### [MONDO:0002305](http://purl.obolibrary.org/obo/MONDO_0002305)
**Label:** thrombophilia

**Subclasses:** [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0008560](http://purl.obolibrary.org/obo/MONDO_0008560) (thrombophilia due to activated protein C resistance), [MONDO:0012872](http://purl.obolibrary.org/obo/MONDO_0012872) (THPH9), [MONDO:0010122](http://purl.obolibrary.org/obo/MONDO_0010122) (congenital thrombotic thrombocytopenic purpura), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein C deficiency, autosomal recessive), [MONDO:0019740](http://purl.obolibrary.org/obo/MONDO_0019740) (acquired thrombotic thrombocytopenic purpura), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein C deficiency), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein C deficiency, autosomal dominant), [MONDO:0008559](http://purl.obolibrary.org/obo/MONDO_0008559) (thrombophilia due to thrombin defect), [MONDO:0002304](http://purl.obolibrary.org/obo/MONDO_0002304) (protein S deficiency), [MONDO:0001243](http://purl.obolibrary.org/obo/MONDO_0001243) (disseminated intravascular coagulation), [MONDO:0001242](http://purl.obolibrary.org/obo/MONDO_0001242) (DIC in newborn), [MONDO:0012876](http://purl.obolibrary.org/obo/MONDO_0012876) (heparin cofactor 2 deficiency), [MONDO:0007594](http://purl.obolibrary.org/obo/MONDO_0007594) (factor 5 excess with spontaneous thrombosis), [MONDO:0010432](http://purl.obolibrary.org/obo/MONDO_0010432) (thrombophilia, X-linked, due to factor 9 defect), [MONDO:0013775](http://purl.obolibrary.org/obo/MONDO_0013775) (thrombomodulin-related bleeding disorder), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (thrombophilia due to protein S deficiency, autosomal dominant), 

**Mapped go classes:** [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0072341](http://purl.obolibrary.org/obo/GO_0072341) (modified amino acid binding), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0031639](http://purl.obolibrary.org/obo/GO_0031639) (plasminogen activation), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0010543](http://purl.obolibrary.org/obo/GO_0010543) (regulation of platelet activation), [GO:1903142](http://purl.obolibrary.org/obo/GO_1903142) (positive regulation of establishment of endothelial barrier), [GO:0061474](http://purl.obolibrary.org/obo/GO_0061474) (phagolysosome membrane), [GO:0031060](http://purl.obolibrary.org/obo/GO_0031060) (regulation of histone methylation), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:0043537](http://purl.obolibrary.org/obo/GO_0043537) (negative regulation of blood vessel endothelial cell migration), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0006825](http://purl.obolibrary.org/obo/GO_0006825) (copper ion transport), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:2000266](http://purl.obolibrary.org/obo/GO_2000266) (regulation of blood coagulation, intrinsic pathway), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0034395](http://purl.obolibrary.org/obo/GO_0034395) (regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035999](http://purl.obolibrary.org/obo/GO_0035999) (tetrahydrofolate interconversion), [GO:0002839](http://purl.obolibrary.org/obo/GO_0002839) (positive regulation of immune response to tumor cell), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0003810](http://purl.obolibrary.org/obo/GO_0003810) (protein-glutamine gamma-glutamyltransferase activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0072378](http://purl.obolibrary.org/obo/GO_0072378) (blood coagulation, fibrin clot formation), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0070829](http://purl.obolibrary.org/obo/GO_0070829) (heterochromatin maintenance), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0004322](http://purl.obolibrary.org/obo/GO_0004322) (ferroxidase activity), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0044537](http://purl.obolibrary.org/obo/GO_0044537) (regulation of circulating fibrinogen levels), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0043171](http://purl.obolibrary.org/obo/GO_0043171) (peptide catabolic process), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0051918](http://purl.obolibrary.org/obo/GO_0051918) (negative regulation of fibrinolysis), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0070012](http://purl.obolibrary.org/obo/GO_0070012) (oligopeptidase activity), [GO:0097037](http://purl.obolibrary.org/obo/GO_0097037) (heme export), [GO:2000504](http://purl.obolibrary.org/obo/GO_2000504) (positive regulation of blood vessel remodeling), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0036019](http://purl.obolibrary.org/obo/GO_0036019) (endolysosome), 

**Class expressions from DL-Learner:**

- Thing 53.26%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.92%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.92%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.28%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005552](http://purl.obolibrary.org/obo/GO_0005552) (obsolete polyubiquitin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005551](http://purl.obolibrary.org/obo/GO_0005551) (obsolete ubiquitin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005541](http://purl.obolibrary.org/obo/GO_0005541) (obsolete acyl-CoA or acyl binding) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005533](http://purl.obolibrary.org/obo/GO_0005533) (obsolete N-acetylgalactosamine lectin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005532](http://purl.obolibrary.org/obo/GO_0005532) (obsolete mannose binding lectin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005531](http://purl.obolibrary.org/obo/GO_0005531) (obsolete galactose binding lectin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005530](http://purl.obolibrary.org/obo/GO_0005530) (obsolete lectin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005529](http://purl.obolibrary.org/obo/GO_0005529) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005517](http://purl.obolibrary.org/obo/GO_0005517) (obsolete calmodulin inhibitor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005514](http://purl.obolibrary.org/obo/GO_0005514) (obsolete calcium ion storage activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.28%


